EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome-wide CRISPR knockout screen identifies activating transcription factor (ATF1) as an activator of HIV gene expression

Alona Kuzmina, Seraj Wattad, Praveenkumar Murugavelu, Noa Amir, Nili Tickotsky, Liron Levin, Ran Taube iD

mBio · 2025

DOI: 10.1128/mbio.00557-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Alona Kuzmina und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Shraga Segal Department of Microbiology Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Isr…. Hauptthemen laut MEDLINE: Gene Expression Regulation, Viral, HIV-1, Activating Transcription Factor 1. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States-Israel Binational Science Foundation, Israel Science Foundation, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiretroviral therapy against the human immunodeficiency virus (HIV) has significantly prolonged the life span of people living with HIV, transforming viral infection into a latent condition that is characterized with undetectable viral loads. Yet, a complete cure of infection is out of reach, as transcriptionally silent but replication-competent proviruses persist in a long-lived reservoir that is resistant to therapy. The current work follows a genome-wide CRISPR knockout screen in human CD4 + T cells and defines the activating transcription factor 1 (ATF1) as an activator of HIV gene transcription with elevated expression levels in cells that carry transcriptionally active provirus. Additional gain and loss-of-function experiments show that depletion of ATF1 promotes latency. ATF1 directly occupies the HIV promoter, where it regulates the recruitment of RNA Polymerase II and the levels of H3K9me3 histone repression mark. Genome-wide, ATF1 binds cellular gene promoters. Among its targets, ATF1 modulates the levels of CCR5 antisense lncRNA, thereby regulating the protein expression of the CCR5 HIV co-receptor. We conclude that ATF1 is an activator of gene transcription that dictates HIV gene expression via both direct and indirect mechanisms. IMPORTANCE HIV persists in resting CD4 + primary infected cells, forming a reservoir that is resistant to therapy, and thus a main barrier toward elimination of viral infection. An understanding of the mechanisms that control HIV gene expression and drive viral latency is therefore of high clinical importance. This study identifies activating transcription factor 1 (ATF1) as an activator of HIV gene expression. ATF1 binds the HIV promoter, where it modulates the occupancy of RNA Polymerase II and the levels of H3K9me3 histone repression mark. Genome-wide, ATF1 also occupies cellular promoters. One target of ATF1 is the antisense (AS) lncRNA. Through binding to CCR5-AS lncRNA, ATF1 induces CCR5 mRNA stability, thereby indirectly controlling HIV infection. Overall, we provide an additional understanding of the host transcription pathways that regulate HIV gene expression and potentially open new ways to manipulate its reservoir size.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene Expression Regulation, ViralHIV-1Activating Transcription Factor 1HumansCD4-Positive T-LymphocytesVirus LatencyPromoter Regions, GeneticCRISPR-Cas SystemsHIV InfectionsGene Knockout TechniquesReceptors, CCR5Clustered Regularly Interspaced Short Palindromic Repeats

Stichwörter der Autor:innen

CCR5 antisense lncRNACCR5 co-receptorHIV gene transcription regulationactivating factor (ATF1)latency

Substanzen

Activating Transcription Factor 1ATF1 protein, humanReceptors, CCR5CCR5 protein, human

Autor:innen und Institutionen

  • The Shraga Segal Department of Microbiology Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
  • Bioinformatics Core Facility, Ilse Katz Institute for Nanoscale Science and Technology, Ben-Gurion University of the Negev, Be'er Sheva, Israel.

ORCID-Profile: Ran Taube

Förderung

  • United States-Israel Binational Science Foundation
  • Israel Science Foundation
  • Deutsche Forschungsgemeinschaft
  • All of Us Research Program (All of Us NIH)
  • United States–Israel Binational Science Foundation

Zitieren

APA

Kuzmina, A., Wattad, S., Murugavelu, P., Amir, N., Tickotsky, N., Levin, L., & Taube, R. (2025). Genome-wide CRISPR knockout screen identifies activating transcription factor (ATF1) as an activator of HIV gene expression. mBio. https://doi.org/10.1128/mbio.00557-25

Vancouver

Kuzmina A, Wattad S, Murugavelu P, Amir N, Tickotsky N, Levin L, et al. Genome-wide CRISPR knockout screen identifies activating transcription factor (ATF1) as an activator of HIV gene expression. mBio. 2025. doi:10.1128/mbio.00557-25

BibTeX
@article{Kuzmina2025,
  author = {Kuzmina, Alona and Wattad, Seraj and Murugavelu, Praveenkumar and Amir, Noa and Tickotsky, Nili and Levin, Liron and Taube, Ran},
  title = {Genome-wide CRISPR knockout screen identifies activating transcription factor (ATF1) as an activator of HIV gene expression},
  journal = {mBio},
  year = {2025},
  doi = {10.1128/mbio.00557-25}
}
Kostenlos starten →